Levetiracetam 500 mg

DRUG4 trials

Sponsors

UCB Pharma SA, UCB Japan Co. Ltd., UCB Pharma, Vanderbilt University Medical Center

Conditions

Epilepsies, PartialGeneralized EpilepsyHealthy SubjectsRenal ImpairmentsSchizophrenia; Psychosis

Phase 2

Pharmacologic Modulation of Hippocampal Activity in Psychosis

TerminatedNCT04277936

Vanderbilt University Medical CenterSchizophrenia; Psychosis

Start: 2020-05-11End: 2020-08-31Updated: 2021-08-05

Phase 3

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

CompletedNCT00150748

UCB Pharma SAGeneralized Epilepsy

Start: 2001-11-30End: 2007-07-31Updated: 2020-07-29

A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

CompletedNCT00280696

UCB Japan Co. Ltd.Epilepsies, Partial

Start: 2005-11-30End: 2007-11-30Updated: 2015-02-11

Phase 4

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

CompletedNCT01491113

UCB PharmaHealthy Subjects, Renal Impairments

Start: 2011-11-30End: 2012-11-30Updated: 2014-02-10

Related Papers

Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.

2011-11-0234 citations